ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease? 2001

J T Kielstein, and J C Frölich, and H Haller, and D Fliser
Department of Nephrology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D019001 Nitric Oxide Synthase An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE. NO Synthase,Nitric-Oxide Synthase,Nitric-Oxide Synthetase,Nitric Oxide Synthetase,Oxide Synthase, Nitric,Synthase, Nitric Oxide

Related Publications

J T Kielstein, and J C Frölich, and H Haller, and D Fliser
February 2015, Clinica chimica acta; international journal of clinical chemistry,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
February 2014, Inflammation,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
January 2008, Renal failure,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
January 2011, Clinical rheumatology,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
March 2014, International journal of molecular sciences,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
February 2001, Kidney international. Supplement,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
January 2013, Current topics in medicinal chemistry,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
January 2009, Internal medicine (Tokyo, Japan),
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
January 2007, Clinical biochemistry,
J T Kielstein, and J C Frölich, and H Haller, and D Fliser
July 2005, Vascular medicine (London, England),
Copied contents to your clipboard!